Helicobacter bilis infection accelerates and H-hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice

被引:116
作者
Maggio-Price, L
Shows, D
Waggie, K
Burich, A
Zeng, WP
Escobar, S
Morrissey, P
Viney, JL
机构
[1] Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA
[2] Immunex Corp, Dept Immunobiol, Seattle, WA USA
[3] ZymoGenet Inc, Seattle, WA USA
关键词
D O I
10.1016/S0002-9440(10)64894-8
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
mdr1a-deficient mice lack P-glycoprotein and spontaneously develop colitis with age. Helicobacter spp. are gram-negative organisms that have been associated with colitis in certain mouse strains, but Helicobacter spp. have been excluded as contributing to the spontaneous colitis that develops in mdr1a -/- mice. We wished to determine whether infection with either H. bilis or H. hepaticus would accelerate the development of inflammatory bowel disease (IBD) in mdr1a -/- mice. We found that H. bilis infection induced diarrhea, weight loss, and IBD in mdr1a-/- mice within 6 to 17 weeks post-inoculation and before the expected onset of spontaneous IBD. Histopathology of H. bilis-induced IBD included crypt hyperplasia, inflammatory cell infiltrates, crypt abscesses, and obliteration of normal gat architecture. Reverse transcription-polymerase chain reaction and Taqman analysis from colonic tissue showed increased transcripts for interferon-gamma and interleukin-10 from H. bilis-infected colitic mdr1a-/- mice. Additionally, mesenteric lymph nodes had increased cellularity with expansion of CD4(+) and CD8(+) T cells and B cells and increased proliferation to soluble H. bilis antigens with elaboration of interferon-gamma, tumor necrosis factor-a and interleukin-10. in contrast, H. hepaticus infection of mdr1a-/- mice did not accelerate disease but rather delayed the onset of spontaneous colitis which was milder in severity. mdr1a-/- mice infected with Helicobacter spp. may provide a useful tool to explore the pathogenesis of microbial-induced IBD in a model with a presumed epithelial. cell "barrier" defect.
引用
收藏
页码:739 / 751
页数:13
相关论文
共 60 条
[1]   An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation [J].
Asseman, C ;
Mauze, S ;
Leach, MW ;
Coffman, RL ;
Powrie, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) :995-1003
[2]   Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses [J].
Berg, DJ ;
Davidson, N ;
Kuhn, R ;
Muller, W ;
Menon, S ;
Holland, G ;
ThompsonSnipes, L ;
Leach, MW ;
Rennick, D .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (04) :1010-1020
[3]   Colitis in transgenic and knockout animals as models of human inflammatory bowel disease [J].
Bhan, AK ;
Mizoguchi, E ;
Smith, RN ;
Mizoguchi, A .
IMMUNOLOGICAL REVIEWS, 1999, 169 :195-207
[4]   A family of drug transporters: The multidrug resistance-associated proteins [J].
Borst, P ;
Evers, R ;
Kool, M ;
Wijnholds, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (16) :1295-1302
[5]  
Brandwein SL, 1997, J IMMUNOL, V159, P44
[6]   Helicobacter-induced inflammatory bowel disease in IL-10-and T cell-deficient mice [J].
Burich, A ;
Hershberg, R ;
Waggie, K ;
Zeng, WP ;
Brabb, T ;
Westrich, G ;
Viney, JL ;
Maggio-Price, L .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2001, 281 (03) :G764-G778
[7]   Inflammatory bowel disease: An immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus [J].
Cahill, RJ ;
Foltz, CJ ;
Fox, JG ;
Dangler, CA ;
Powrie, F ;
Schauer, DB .
INFECTION AND IMMUNITY, 1997, 65 (08) :3126-3131
[8]   Identification of cdtB homologues and cytolethal distending toxin activity in enterohepatic Helicobacter spp. [J].
Chien, CC ;
Taylor, NS ;
Ge, ZM ;
Schauer, DB ;
Young, VB ;
Fox, JG .
JOURNAL OF MEDICAL MICROBIOLOGY, 2000, 49 (06) :525-534
[9]  
Chin EY, 2000, COMPARATIVE MED, V50, P586
[10]   Colitis induced by enteric bacterial antigen-specific CD4+ T cells requires CD40-CD40 ligand interactions for a sustained increase in mucosal IL-12 [J].
Cong, YZ ;
Weaver, CT ;
Lazenby, A ;
Elson, CO .
JOURNAL OF IMMUNOLOGY, 2000, 165 (04) :2173-2182